Reinventing GPCR drug discovery using systems biology

We integrate experimental and computational pharmacology to reveal critical properties of novel GPCR drug candidates.

The InterAx Platform

Compounds
Compounds

Compounds

Arrow left to right
Arrow left to right
Assays

The InterAx Platform

Assays

Time-resolved cellular assays

Arrow double
Arrow double
Systems biology analysis
Systems biology analysis

Systems biology analysis

Arrow split
Arrow split
Clustered Compounds
Clustered Compounds

Clustering

Arrow merge
Arrow merge
In vivo
In vivo

Better prediction of in vivo effects

Compounds

Time-resolved cellular assays

Systems biology analysis

Clustering

Better prediction of in vivo effects

InterAx helps partners to accelerate and optimize hit‑to‑lead identification for GPCRs.

With Support From

Featured News

SEPT 2019

SEPT 2019

European Union awards InterAx with Horizon 2020 SME Instrument Phase 2 for the integration of machine learning into the InterAx…
AUG 2019

AUG 2019

InterAx Biotech and Boehringer Ingelheim collaborate for enabling the in-depth characterization of drug candidates using the proprietary InterAx systems biology…
MAY 2019

MAY 2019

Next EU Training Network ONCORNET2.0 on oncogenic GPCR networks   The EU has granted 4M euro to Martine Smit and…

Meeting Opportunities

No event found!
Load More